The Belgium Cardiac Surgery Instruments Market is expected to witness growth from $5 Mn in 2022 to $8 Mn in 2030 with a CAGR of 6.60% for the forecasted year 2022-2030. The demand for cardiac surgery tools is rising in Belgium as cardiac diseases are becoming more common. The need for cardiac surgery instruments is expected to increase as the population ages and risk factors like smoking and obesity become more common in Belgium. The market is segmented by type, application and by end user. Some key players in this market include Trasis, Acertys Healthcare, LivaNova, B. Braun, Medline Industries, KLS Martin, and STILLE.
The Belgium-connected healthcare market is projected to grow from $145.99 Mn in 2022 to $1078.57 Mn by 2030, registering a CAGR of 28.4% during the forecast period of 2022 - 2030. The main factors driving the growth would be the ageing population, technological innovation, increasing prevalence of chronic diseases and government support. The market is segmented by type, function and by application. Some of the major players include Agfa Healthcare, Barco, BeWell Innovations, Oracle, Honeywell and Medtronic.
Belgium anti-aging therapeutics market is expected to witness growth from $1 Mn in 2022 to $5 Mn in 2030 with a CAGR of 16.53% for the forecasted year 2022-2030 due to the rising geriatric population and the emergence of novel and more advanced therapeutic options for anti-aging in Belgium. The Belgium anti-aging therapeutics market is segmented by product, treatment, target group, type of aging, type of molecules, mechanism of action, ingredient, and by distribution channel. Bioxodes, Biotalys, and Elysium Health are some of the leading companies in Belgium anti-aging therapeutics market.
The Belgium Biomaterials in Healthcare Market is expected to witness growth from $344 Mn in 2022 to $927 Mn in 2030 with a CAGR of 13.20% for the forecasted year 2022-2030. The aging populace in Belgium is driving up demand for biomaterials in Belgium Biomaterials in Healthcare market. The market is segmented by type and by application. Some key players in this market include: Trasis, Acertys Healthcare, BASF SE, Johnson and Johnson, Medtronic and Evonik Industries.
Belgium's Attention Deficit Hyperactivity Disorder (ADHD) therapeutics market is expected to witness growth from $65 Mn in 2022 to $116 Mn in 2030 with a CAGR of 7.5% for the year 2022-2030 due to factors like rising cases of ADHD among the Belgian population and the improved health expenditure for greater access to ADHD medications. The Belgium ADHD therapeutics market is segmented by drug, drug type, demographics, and by distribution channel. Some of the major players in the market include Celyad, Confo Therapeutics, and Advanz Pharmaceuticals.
Belgium 3D Printing Medical Device Market is expected to witness growth from $7 Mn in 2022 to $22 Mn in 2030 with a CAGR of 16.30% for the forecasted year 2022-2030. Because of the rising demand for personalised medical devices, advancements in 3D printing technology, rising healthcare costs, an increase in the number of 3D printing businesses, and government support, the market for 3D printed medical devices in Belgium is anticipated to expand in the upcoming years. The market is segmented by application, by technology and by end user. Some key players in this market include: CERHUM, Spentys, Stryker, Stratasys, GE Additive, Prodways Group and Siemens Healthineers.
The Belgium healthcare claims management market is projected to grow from $58.74 Mn in 2022 to $315.83 Mn by 2030, registering a CAGR of 23.4% during the forecast period of 2022 - 2030. The main factors driving the growth would be an increase in chronic diseases, a focus on the quality of care, technological advancements and an ageing population. The market is segmented by component, type, by delivery mode and end-user. Some of the major players include Qover, Allianz, AXA and Cognizant.
The Belgium oncology clinical trials market is projected to grow from $27.8 Mn in 2022 to $42.7 Mn by 2030, registering a CAGR of 5.5% during the forecast period of 2022-30. The market will be driven by increasing demand for innovative cancer therapies and a growing focus on personalized medicine. The market is segmented by phase, by study design & by indication. Some of the major players include Pfizer Inc., Roche Holding AG & Galapagos NV.
By 2030, it is anticipated that the Belgium Liver Cancer Therapeutics market will reach a value of $23.6 Mn from $6.4 Mn in 2022, growing at a CAGR of 17.6 % during 2022-2030. Liver Cancer Therapeutics in Belgium is dominated by a few domestic pharmaceutical companies such as IBA Molecular, OncoDNA and Theraclion. The Liver Cancer Therapeutics market in Belgium is segmented into different types of cancer and different therapy type. Some of the major factors affecting the Belgium Liver Cancer Therapeutics market are the growing prevalence of liver cancer and the high cost and side effects related to certain liver cancer therapies.
The Belgium Neurology Clinical Trials market is projected to grow from $11.5 Mn in 2022 to $17.7 Mn by 2030, registering a CAGR of 5.5% during the forecast period of 2022 - 2030. The market will be driven by the rising prevalence of neurological disorders and a favourable regulatory environment. The market is segmented by phase, by study design & by indication. Some of the major players include UCB, Biogen Inc & Icometrix.
Belgium's Patient Support Programs (PSP) market is expected to grow from $xx Bn in 2022 to $xx Bn in 2030 with a CAGR of xx% for the year 2022-2030 mainly due to the increasing demand for patient-centric care and individualized treatment option in Belgium. The Belgium Patient Support Programs (PSP) market is segmented by functionality outlook, therapeutic outlook, application outlook, and end user. Some of the major PSP operators in the Belgium Patient Support Programs (PSP) market are Novellas Healthcare, Ashfield Engage, and Remedus.
The Belgium patient engagement solutions market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The main factors driving the growth would be a high level of technology adoption, a growing focus on patient-centred care, an ageing population and government support. The market is segmented by component, delivery mode, application, therapeutic area, functionality and by end-user. Some of the major players include Byteflies, Avanade, CGI, Siemens Healthineers and Wolters Kluwer.
By 2030, it is anticipated that the Belgium Nutrition and Supplements market will reach a value of $xx Bn from $xx Bn in 2022, growing at a CAGR of xx% during 2022-2030. The nutrition and supplements market in Belgium is primarily dominated by local players such as Vitals, Physalis, and Fytexia. The market for nutrition and supplements in Belgium is primarily driven by an inclination towards better health infrastructure, government regulations and increasing consumer awareness of health and lifestyle. The Belgium nutrition and supplements market in Belgium is segmented by Type, Product, application, and Distribution Channel.
The Belgium Neurology Device Market is expected to witness growth from $xx Bn in 2022 to $xx Bn in 2030 with a CAGR of xx% for the forecasted year 2022-2030. Belgium's market for neurological devices is developing as a result of an aging population, improved healthcare facilities, and an increase in neurological illnesses. The market is segmented by product type and by the end user. Major Key players in Malaysia's neurology devices market include Medec, Heyer nv, Nihon Kohden, Medtronic, Boston Scientific, and Johnson and Johnson.
The higher success rates of breast cancer therapeutics are leading to the growth of Belgium's breast cancer therapeutics market from $xx Bn in 2022 to $xx Bn in 2030 with a CAGR of xx% for the year 2022-2030. The market is segmented by therapy, by cancer type, and by distribution channel. Some of the key market players in Belgium breast cancer therapeutics are Alter Pharma Group, Odyssea Pharma, and Bristol-Myers Squibb.
The Belgium Artificial Intelligence (AI) in the diagnostics market is projected to grow from $xx Bn in 2022 to $xx Bn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The market will be driven by Belgium’s vibrant AI startup environment and government initiatives such as “The National Strategy to Develop Artificial Intelligence (AI)”. The market is segmented by component & by diagnosis. Some of the major players include IBM Watson Health, Icometrix & Agfa HealthCare.
The Belgium Palliative care market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The main factors driving the growth would be the ageing population, public awareness and government support. The market is segmented by service type and by the end user. Some of the major players include Hospice Pacheco, Coda Hospice, Jardin Hospice and Ter duinen Hospice.
The Belgium 3D Imaging market is projected to grow from $xx Bn in 2022 to $xx Bn by 2030, registering a CAGR xx% during the forecast period of 2022 - 2030. The market will be driven by increased healthcare investments, the rising prevalence of chronic illnesses & rising demand for customized treatment. The market is segmented by product, application, by end-user & by portability. Some of the major players include GE Healthcare, Siemens Healthineers & Agfa HealthCare
By 2030, it is anticipated that the Belgium HIV therapeutics market will reach a value of $xx Mn from $xx Mn in 2022, growing at a CAGR of xx% during 2022-2030. The market is primarily dominated by local players such as Mylan Belgium, Ablynx, and UCB. The market is driven by government policies and initiatives for the management of HIV infections in the country. The HIV therapeutics market in Belgium is segmented by type, product, and geography, end user, and distribution channel.
By 2030, it is anticipated that the Belgium Dermatology drugs market will reach a value of $xx Mn from $xx Mn in 2022, growing at a CAGR of xx% during 2022-2030. The market is primarily dominated by local players such as ThromboGenics, Galapagos, and UCB. The market is driven by teledermatology consultations, modest clinical trials, and awareness about dermatological health. The dermatology drug market in Belgium is segmented by drug class, drug type, prescription mode, indication, route of administration, end-user, and distribution channel.
The Belgium home healthcare market was valued at $XX Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of XX% from 2022 to 2030 and will reach $XX Bn in 2030. One of the main reasons propelling the growth of this market is the introduction of newer technologies, and the aging population. The market is segmented by component and product. Some key players in this market are Intermutualistisch Agentschap, Médicus, Zorgbedrijf
The Belgium Electronic Health Record (EHR) market size was valued at $xx Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of xx% from 2022 to 2030 and will reach $xx Bn in 2030. Belgium's EHR market growth will grow as EHRs can assist healthcare practitioners in making financial savings by streamlining processes, lowering administrative expenses, and lessening the demand for paper documentation. The key market players are Medtech, Egton Medical Information Systems, Orion Health, Sagemcom, and others.
The Belgium Digital Health market is projected to grow from $xxBn in 2022 to $xxBn by 2030, registering a CAGR xx% during the forecast period of 2022 - 2030. The market will be driven by the rising demand for cost-effective healthcare & increasing aging pollution. The market is segmented by solution, by deployment & by end-use. Some of the major players include Indigo, Icometrix & Arseus Medical.
The Belgium Bioinformatics market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The main factors driving the growth would be the strong presence of pharmaceutical and biotech firms as well as government funding for R&D. The market is segmented by technology and by application. Some of the major players include BioLizard (BEL), BISC Global (BEL), InSilico Genomics, Agilent Technologies, and IBM Life Sciences.
The Belgium dental care market size is at around $xx Bn in 2022 and is projected to reach $xx Bn in 2030, exhibiting a CAGR of 4.7% during the forecast period. The world’s most advanced healthcare system encourages innovation in dental care and with high standards of care demanded the market is a flourishing ground for players like Dentale, Dental Avenue, and Dental Health Group. This report is segmented by treatment type, age group, clinical setup, and by demography and provides rich insights.